In a major boost for India’s generics industry, the Delhi High Court has ruled that Macleods Pharmaceuticals may continue its ...

UK pharma major GSK has entered an agreement to acquire 35Pharma Inc, a Canada-based, private, clinical-stage biopharmaceutical company specialised in the development of novel protein-based ...

Australian biotech Neurizon (ASX: NUZ) has dosed the first participant with NUZ-001 in Regimen I of the US-based HEALEY ALS Platform Trial, launching a key Phase II/III study in amyotrophic lateral ...

Ireland headquartered Alkermes (Nasdaq: ALKS) has announced that Richard Pops will retire from his role as chief executive (CEO), effective July 31, 2026.